Guillain-Barré syndrome is a rare but serious neurological condition that can cause progressive limb weakness and eventual paralysis, with an annual incidence of one to four cases per 100,000 people ...

A new multinational study analyzing data from over 230 million people across 20 global sites highlights the relationship between SARS-CoV-2 infection, certain COVID-19 vaccines, and Guillain ...

Guillain-Barre syndrome (GBS) is a rare but serious autoimmune disorder in which the body's immune system mistakenly attacks the peripheral nerves, leading to muscle weakness, numbness, and, in ...

--Hansa Biopharma AB, "Hansa" today announced that it will host a virtual investor event on Guillain-Barré syndrome on Monday, June 16, 2025 at 14:00 CEST/ 8:00 AM EDT. David R. Cornblath, MD ...

A case of Guillain-Barre syndrome in a previously healthy child who received a hepatitis A vaccination 5 days before onset of symptoms is described.

One step at a time, those who are diagnosed with rare neuropathic conditions such as GBS or CIDP prove it's possible to get ...

Peruvian authorities Saturday declared a 90-day nationwide sanitary emergency due to the “unusual increase” in cases of Guillain-Barré Syndrome, it was reported in Lima. As per President Dina ...

Cite this: Possible Association of Guillain-Barre Syndrome and Hepatitis A Vaccination - Medscape - Jun 01, 2004. Abstract and Introduction; Case Report; Discussion; References; Tables.

Studies have found important benefits from a newer vaccine and enhanced versions of older ones, and one vaccine may confer a ...

For older adults who express more confidence in vaccine safety than younger groups, the past few months have brought welcome ...

Recent federal and state efforts, as well as changes undertaken by insurance companies themselves, have attempted to improve ...